AUM $10.7MER 0.55%NAV $25.16Holdings —Inception Sep 2026
Price Chart
Key Statistics
Previous Close
$24.66Day Range
$24.59$25.20
52-Week Range
$22.72$25.59
Avg Volume
1.9KDividend Yield
—Expense Ratio
0.55%AUM
$10.7MShares Outstanding
400.0KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Country Allocation
| Country | Weight % |
|---|---|
| United States | 97.68% |
| United Kingdom | 1.44% |
| Canada | 0.63% |
| France | 0.25% |
Fund Information
- Issuer
- T. Rowe
- Inception Date
- Sep 16, 2026
- Description
- T. Rowe Price Biotech ETF is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing primarily in biotechnology and life sciences companies. The fund focuses on companies developing innovative therapies, medicines, and technologies across areas such as biotechnology, pharmaceuticals, and medical research. T. Rowe Price lists the fund under the ticker TDNA.
The T. Rowe Price Biotech ETF (TDNA) is an exchange-traded fund issued by T. Rowe that launched on Sep 16, 2026. It currently manages $10.7M in assets under management. The fund charges an expense ratio of 0.55%.
Top 10 holdings represent 28.6% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ARGX | ARGENX SE ADR ADR | 5.05% | 637 | $572K |
| 2 | KYMR | KYMERA THERAPEUTICS INC COMMON STOCK USD.0001 | 4.42% | 4,083 | $501K |
| 3 | KOD | KODIAK SCIENCES INC COMMON STOCK USD.0001 | 2.83% | 3,190 | $320K |
| 4 | NTRA | NATERA INC COMMON STOCK | 2.54% | 660 | $288K |
| 5 | INSM | INSMED INC COMMON STOCK USD.01 | 2.53% | 2,567 | $286K |
| 6 | UTHR | UNITED THERAPEUTICS CORP COMMON STOCK USD.01 | 2.40% | 457 | $271K |
| 7 | VRTX | VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01 | 2.32% | 487 | $263K |
| 8 | RVMD | REVOLUTION MEDICINES INC COMMON STOCK | 2.20% | 1,307 | $249K |
| 9 | MRNA | MODERNA INC COMMON STOCK USD.0001 | 2.20% | 1,116 | $249K |
| 10 | PCVX | VAXCYTE INC COMMON STOCK USD.001 | 2.09% | 3,779 | $237K |
| 11 | SYRE | SPYRE THERAPEUTICS INC COMMON STOCK USD.0001 | 1.98% | 2,267 | $224K |
| 12 | BBIO | BRIDGEBIO PHARMA INC COMMON STOCK | 1.94% | 3,106 | $220K |
| 13 | PRAX | PRAXIS PRECISION MEDICINES I COMMON STOCK USD.0001 | 1.89% | 741 | $214K |
| 14 | DNTH | DIANTHUS THERAPEUTICS INC COMMON STOCK USD.001 | 1.79% | 2,454 | $203K |
| 15 | RYTM | RHYTHM PHARMACEUTICALS INC COMMON STOCK | 1.77% | 2,149 | $200K |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +2.17% | |
| 1W | +1.95% | |
| 1M | +6.13% | |
| 3M | -0.04% | |
| 6M | -0.04% | |
| YTD | -0.04% | |
| 1Y | -0.04% | |
| 3Y | -0.04% | |
| 5Y | -0.04% |
Moving Averages
20-Day MA
$24.10
Above 20-Day MA50-Day MA
$24.40
Above 50-Day MA200-Day MA
$24.40
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$25.59
Current Price
$25.20
52-Week Low
$22.72
$22.72$25.59
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with TDNA:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.